0 Yorumlar
0 hisse senetleri
125 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Leukemia Therapeutics Market Expands Through Innovation in Precision OncologyMarket Estimation & Definition The Leukemia Therapeutics Market is poised for substantial growth, driven by the increasing prevalence of blood cancers and continuous advancements in oncology treatment approaches. According to the latest analysis by Stellar Market Research, the market was valued at USD 16.99 billion in 2024 and is expected to reach nearly USD 29.92 billion by 2032,...0 Yorumlar 0 hisse senetleri 584 Views 0 önizleme
-
Peptide Based Cancer Therapeutics Market – Targeted Therapies & Precision Oncology TrendsAccording to a new report by Polaris Market Research, the global peptide-based cancer therapeutics market was valued at USD 8.58 billion in 2019 and is projected to reach USD 17.18 billion by 2027, expanding at a CAGR of 9.1% over the forecast period. Growth is underpinned by the rising global prevalence of cancer, innovations in peptide-based treatment approaches, and increasing...0 Yorumlar 0 hisse senetleri 232 Views 0 önizleme
-
Pharmaceutical Fine Chemicals Market Fueled by Oncology Therapeutics and Supply Chain DiversificationPharmaceutical Fine Chemicals Market to Reach USD 378 Billion by 2036, Driven by Oncology API Demand, Supply Chain Localization, and Generic Drug Expansion The global Pharmaceutical Fine Chemicals Market is poised for significant expansion over the coming decade, supported by accelerating pharmaceutical innovation, rising demand for high-purity active pharmaceutical ingredients (APIs),...0 Yorumlar 0 hisse senetleri 686 Views 0 önizleme
-
Ovarian Cancer Drugs Market: Hospital Pharmacy Distribution TrendsThe Ovarian Cancer Drugs Market is evolving as the need for effective cancer treatments increases worldwide. Valued at USD 3.4 billion in 2022, the Ovarian Cancer Drugs Market is projected to reach USD 5.7 billion by 2030, expanding at a CAGR of 6.6% from 2023 to 2030. Growing ovarian cancer incidence, advances in targeted medicines, and the development of innovative therapies are supporting...0 Yorumlar 0 hisse senetleri 9 Views 0 önizleme